Skip to main content

Opioids..decoupling pain from itching...here we go


Animal researchers are making remarkable progress in understanding the complex neurophysiologic interrelationships between the sensations of itch and pain. Recent discoveries in this area have the potential to transform the clinical management of human pain, especially for patients who experience intense itching in association with the in-hospital administration of epidural morphine. Among the most promising of these discoveries, in late 2011, using a mouse model, a group from the Washington University School of Medicine was successful in uncoupling the desired analgesic effect of morphine from the unwanted effect of itching.1
The strategy employed by the researchers was a sequential series of molecular, cellular, biochemical, and behavioral experiments that culminated in blocking one variant of the μ-opioid receptor, MOR1D.1 The group’s strategy built on earlier findings that showed MOR1 is the predominant receptor mediating the analgesic effects of morphine in the spinal cord, and that one particular isoform, MOR1D (differing from MOR1 by only 7 amino acids), induces itching by activating gastrin-releasing peptide receptor (GRPR).1 GRPR is co-expressed with MOR1D in spinal cord neurons and importantly, transmits the sensation of itch but not pain.1,2 Prior to the discovery that GRPR-expressing neurons represent a “labeled line” for the transmission of itch signals in the spinal cord, suppression of pain signaling was thought to be necessary for the perception of itch (a concept termed the “selectivity” theory).1,3 The finding of an opioid receptor variant, MOR1D, that does not alleviate pain, together with the discovery of an itch-specific receptor, GRPR, represents a noteworthy scientific breakthrough. Similar investigative approaches are now being applied to decoupling analgesia from the other dose-limiting side effects of opioids, namely nausea, constipation, and respiratory depression.4,5 In addition, novel therapies for debilitating itching may also develop out of this important research aimed at improving the tolerability of opioids.2


1. Liu X, Liu Z, Sun Y, et al. Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids. Cell 2011 October 14;147(2):447-458.  [PMID: 22000021]

2. Cevikbas F, Steinhoff M, Ikoma A. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther 2011 December;17(6):742-749.  [PMID: 20950328]

3. Miyamoto T, Patapoutian A. Why Does Morphine Make You Itch? [editorial]. Cell 2011 October 14;147(2):261-262.  [PMID: 22000005]

4. Dryden J. Researchers block morphine’s itchy side effect. October 13, 2011. Newsroom. Washington University in St. Louis. Copyright 2010.https://news.wustl.edu/news/Pages/22805.aspx.

5. Ross SE. Pain and itch: insights into the neural circuits of aversive somatosensation in health and disease. Current Opinion in Neurobiology 2011 December;21(6):880-887.  [PMID: 22054924]

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...
Post a Comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more